• Title of article

    Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression

  • Author/Authors

    Maria Genander، نويسنده , , Michael M. Halford، نويسنده , , Nan-Jie Xu، نويسنده , , Malin Eriksson، نويسنده , , Zuoren Yu، نويسنده , , Zhaozhu Qiu، نويسنده , , Anna Martling، نويسنده , , Gedas Greicius، نويسنده , , Sonal Thakar، نويسنده , , Timothy Catchpole، نويسنده , , Michael J. Chumley، نويسنده , , Sofia Zdunek، نويسنده , , Chenguang Wang، نويسنده , , Torbjorn Holm، نويسنده , , Stephen P. Goff، نويسنده , , Sven Pettersson، نويسنده , , Richard G. Pestell، نويسنده , , Mark Henkemeyer، نويسنده , , Jonas Frisén، نويسنده ,

  • Issue Information
    هفته نامه با شماره پیاپی سال 2009
  • Pages
    14
  • From page
    679
  • To page
    692
  • Abstract
    Signaling proteins driving the proliferation of stem and progenitor cells are often encoded by proto-oncogenes. EphB receptors represent a rare exception; they promote cell proliferation in the intestinal epithelium and function as tumor suppressors by controlling cell migration and inhibiting invasive growth. We show that cell migration and proliferation are controlled independently by the receptor EphB2. EphB2 regulated cell positioning is kinase-independent and mediated via phosphatidylinositol 3-kinase, whereas EphB2 tyrosine kinase activity regulates cell proliferation through an Abl-cyclin D1 pathway. Cyclin D1 regulation becomes uncoupled from EphB signaling during the progression from adenoma to colon carcinoma in humans, allowing continued proliferation with invasive growth. The dissociation of EphB2 signaling pathways enables the selective inhibition of the mitogenic effect without affecting the tumor suppressor function and identifies a pharmacological strategy to suppress adenoma growth.
  • Journal title
    CELL
  • Serial Year
    2009
  • Journal title
    CELL
  • Record number

    1020064